HBI Deals+Insights / M&A/IPOs

All change in dialysis

The dialysis sector looks certain to consolidate fast in Europe. Bankers say that Bridgepoint is keen to exit Diaverum, which it bought near the height of the boom in late 2007. Meanwhile, they also say that Baxter looks near certain to buy EQT-backed Gambro.

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.


  Results (1) from